Organon & Co. (OGN) Q2 2024 Earnings Call Transcript Eli Lilly, Organon expand distribution deal for migraine drug Roth MKM says Small-Cap Value reaches key technical support, lists 14 "bullish ...

Organon & Co. is a science based global pharmaceutical company, which develops and delivers innovative health solutions through a portfolio of prescription therapies within women’s health ...

JERSEY CITY, N.J. (AP) — JERSEY CITY, N.J. (AP) — Organon & Co. (OGN) on Thursday reported fourth-quarter net income of $109 million. On a per-share basis… ...

JERSEY CITY, N.J., March 08, 2025--Organon (NYSE: OGN), a global healthcare company with a focus on women’s health, today announced results from an analysis of the Phase 3 ADORING 3 open-label ...